Transmission and population dynamics of HTLV-I infection

Seydel J, Krämer A (1996)

Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Abstract / Bemerkung
We present a modelling approach for transmission and population dynamics of human T-cell lymphotropic-virus-type-I (HTLV-I) infection. A steady-state analysis of the model was used to estimate transmission rates for males and females. The rate of heterosexual transmission was 2.7 times higher if the carrier was male. A dynamic transmission model was developed and used to study the impact of different intervention measures in the Jamaican population. Interventions concerning horizontal (heterosexual) transmission exceeds the effect of breaking vertical (mother-to-child) transmission, although breast feeding also has an important impact on the total number of infected individuals. (C) 1996 Wiley-Liss, Inc.


Seydel J, Krämer A. Transmission and population dynamics of HTLV-I infection. INTERNATIONAL JOURNAL OF CANCER. 1996;66(2):197-200.
Seydel, J., & Krämer, A. (1996). Transmission and population dynamics of HTLV-I infection. INTERNATIONAL JOURNAL OF CANCER, 66(2), 197-200. doi:10.1002/(SICI)1097-0215(19960410)66:2<197::AID-IJC10>3.0.CO;2-A
Seydel, J., and Krämer, A. (1996). Transmission and population dynamics of HTLV-I infection. INTERNATIONAL JOURNAL OF CANCER 66, 197-200.
Seydel, J., & Krämer, A., 1996. Transmission and population dynamics of HTLV-I infection. INTERNATIONAL JOURNAL OF CANCER, 66(2), p 197-200.
J. Seydel and A. Krämer, “Transmission and population dynamics of HTLV-I infection”, INTERNATIONAL JOURNAL OF CANCER, vol. 66, 1996, pp. 197-200.
Seydel, J., Krämer, A.: Transmission and population dynamics of HTLV-I infection. INTERNATIONAL JOURNAL OF CANCER. 66, 197-200 (1996).
Seydel, Johannes, and Krämer, Alexander. “Transmission and population dynamics of HTLV-I infection”. INTERNATIONAL JOURNAL OF CANCER 66.2 (1996): 197-200.

5 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Age and gender specific prevalence of HTLV-1.
Eshima N, Iwata O, Iwata S, Tabata M, Higuchi Y, Matsuishi T, Karukaya S., J Clin Virol 45(2), 2009
PMID: 19386541
Locking the two ends of tetrapeptidic HTLV-I protease inhibitors inside the enzyme.
Zhang M, Nguyen JT, Kumada HO, Kimura T, Cheng M, Hayashi Y, Kiso Y., Bioorg Med Chem 16(14), 2008
PMID: 18558491
Analysis of the infection system of human T-cell leukaemia virus type I based on a mathematical epidemic model.
Eshima N, Tabata M, Kikuchi H, Karukaya S, Taguchi T., Stat Med 20(24), 2001
PMID: 11782041
Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases.
Giuliani M, Rezza G, Lepri AC, Di Carlo A, Maini A, Crescimbeni E, Palamara G, Prignano G, Caprilli F., Sex Transm Dis 27(2), 2000
PMID: 10676975

18 References

Daten bereitgestellt von Europe PubMed Central.

Blattner, 1989
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma.
Blattner WA, Kalyanaraman VS, Robert-Guroff M, Lister TA, Galton DA, Sarin PS, Crawford MH, Catovsky D, Greaves M, Gallo RC., Int. J. Cancer 30(3), 1982
PMID: 6290401

Gessain, Lancet (), 1985

Gessain, Lancet (), 1986

Hanchard, 1990

Hino, Jap. J. Cancer Res. 76(), 1985

Hinuma, Proc. nat. Acad. Sci. (Wash.) 78(), 1981
Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.
Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, Kikuchi M, Ichimaru M, Yunoki K, Sato I, Matsuo R, Takiuchi Y, Uchino H, Hanaoka M., Int. J. Cancer 29(6), 1982
PMID: 6980846
The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.
Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS., J. Acquir. Immune Defic. Syndr. 3(11), 1990
PMID: 2213510

Krämer, 1989
A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion.
Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, Hanchard B, Blattner WA., Int. J. Cancer 51(6), 1992
PMID: 1639536

Mueller, Cancer Causes Control 2(), 1990

Murphy, 1990
Sexual transmission of human T-lymphotropic virus type I (HTLV-I).
Murphy EL, Figueroa JP, Gibbs WN, Brathwaite A, Holding-Cobham M, Waters D, Cranston B, Hanchard B, Blattner WA., Ann. Intern. Med. 111(7), 1989
PMID: 2789009

Murphy, Amer. J. Epidemiol. 33(), 1991
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.
Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, Goedert JJ, Blattner WA., Int. J. Cancer 43(2), 1989
PMID: 2917802

Poiesz, Proc. nat. Acad. Sci. (Wash.) 77(), 1980

Wiktor, J. acquir. immune-Defic. Syndr. 6(), 1993


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®


PMID: 8603811
PubMed | Europe PMC

Suchen in

Google Scholar